Found: 15
Select item for more details and to access through your institution.
Alemtuzumab-based reduced-intensity conditioning allogeneic tranplantation for myeloma and plasma cell leukemia -- a single institution experience.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
HIV-Negative Plasmablastic Lymphoma: Not in the Mouth.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 185, doi. 10.1016/j.clml.2011.03.008
- By:
- Publication type:
- Article
90Y Ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Treatment of indolent lymphoma in Germany -- results of a representative population-based survey.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Management of multiple myeloma in pregnancy: strategies for a rare challenge.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 198, doi. 10.1016/j.clml.2011.03.002
- By:
- Publication type:
- Article
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 204, doi. 10.1016/j.clml.2011.03.001
- By:
- Publication type:
- Article
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 219, doi. 10.1016/j.clml.2011.03.003
- By:
- Publication type:
- Article
90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 212, doi. 10.1016/j.clml.2011.03.007
- By:
- Publication type:
- Article
Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 237, doi. 10.1016/j.clml.2011.03.005
- By:
- Publication type:
- Article
Management of Multiple Myeloma in Pregnancy: Strategies for a Rare Challenge.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 190, doi. 10.1016/j.clml.2011.03.009
- By:
- Publication type:
- Article
Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia - A Single- Institution Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 242, doi. 10.1016/j.clml.2011.03.004
- By:
- Publication type:
- Article
CLINICAL LYMPHOMA, MYELOMA & LEUKEMIA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/ Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 228, doi. 10.1016/j.clml.2011.03.006
- By:
- Publication type:
- Article